Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for bleeding reduction in hysterectomy
IRCT20210703051769N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of tranexamic acid in menstrual disorders (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: blood loss, blood transfusion and 2 more. Started Sep 2016; status: completed.
02
Drugs
tranexamic acid
03
Conditions
menstrual disorders
Beyond the preview
Go deeper on IRCT20210703051769N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210703051769N1.